A detailed history of Eukles Asset Management transactions in Zoetis Inc. stock. As of the latest transaction made, Eukles Asset Management holds 19,594 shares of ZTS stock, worth $3.46 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
19,594
Previous 19,833 1.21%
Holding current value
$3.46 Million
Previous $3.44 Million 11.34%
% of portfolio
1.57%
Previous 1.51%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$172.58 - $196.48 $41,246 - $46,958
-239 Reduced 1.21%
19,594 $3.83 Million
Q2 2024

Aug 01, 2024

BUY
$145.54 - $178.83 $19,647 - $24,142
135 Added 0.69%
19,833 $3.44 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $150,925 - $182,145
911 Added 4.85%
19,698 $3.33 Million
Q4 2023

Jan 31, 2024

SELL
$151.44 - $200.09 $6,057 - $8,003
-40 Reduced 0.21%
18,787 $3.71 Million
Q3 2023

Oct 25, 2023

BUY
$167.14 - $192.77 $36,937 - $42,602
221 Added 1.19%
18,827 $3.28 Million
Q2 2023

Aug 01, 2023

BUY
$160.94 - $186.23 $27,681 - $32,031
172 Added 0.93%
18,606 $3.2 Million
Q1 2023

Apr 28, 2023

SELL
$145.48 - $175.02 $10,038 - $12,076
-69 Reduced 0.37%
18,434 $3.07 Million
Q4 2022

Jan 27, 2023

BUY
$131.14 - $157.47 $118,157 - $141,880
901 Added 5.12%
18,503 $2.71 Million
Q3 2022

Oct 28, 2022

BUY
$148.29 - $182.55 $1,038 - $1,277
7 Added 0.04%
17,602 $2.61 Million
Q2 2022

Jul 28, 2022

BUY
$155.97 - $200.09 $17,780 - $22,810
114 Added 0.65%
17,595 $3.02 Million
Q1 2022

Apr 27, 2022

SELL
$181.39 - $234.03 $15,962 - $20,594
-88 Reduced 0.5%
17,481 $3.3 Million
Q4 2021

Feb 10, 2022

BUY
$193.69 - $247.03 $73,021 - $93,130
377 Added 2.19%
17,569 $4.29 Million
Q3 2021

Oct 28, 2021

BUY
$189.29 - $209.69 $142,156 - $157,477
751 Added 4.57%
17,192 $3.34 Million
Q2 2021

Jul 27, 2021

BUY
$155.9 - $187.99 $198,928 - $239,875
1,276 Added 8.41%
16,441 $3.06 Million
Q1 2021

Apr 27, 2021

BUY
$144.0 - $169.39 $55,008 - $64,706
382 Added 2.58%
15,165 $2.39 Million
Q4 2020

Jan 26, 2021

BUY
$157.07 - $174.35 $57,644 - $63,986
367 Added 2.55%
14,783 $2.45 Million
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $29,887 - $36,050
218 Added 1.54%
14,416 $2.38 Million
Q2 2020

Jul 29, 2020

BUY
$111.92 - $142.53 $91,326 - $116,304
816 Added 6.1%
14,198 $1.95 Million
Q1 2020

Apr 22, 2020

SELL
$92.66 - $144.94 $67,271 - $105,226
-726 Reduced 5.15%
13,382 $1.58 Million
Q4 2019

Jan 24, 2020

SELL
$116.25 - $133.25 $10,462 - $11,992
-90 Reduced 0.63%
14,108 $1.87 Million
Q3 2019

Oct 29, 2019

SELL
$112.57 - $128.43 $2,701 - $3,082
-24 Reduced 0.17%
14,198 $1.77 Million
Q2 2019

Aug 01, 2019

SELL
$97.98 - $114.28 $1,861 - $2,171
-19 Reduced 0.13%
14,222 $1.61 Million
Q1 2019

Apr 23, 2019

BUY
$81.56 - $100.67 $8,237 - $10,167
101 Added 0.71%
14,241 $1.43 Million
Q4 2018

Jan 22, 2019

BUY
$79.28 - $95.27 $1.12 Million - $1.35 Million
14,140 New
14,140 $1.21 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Eukles Asset Management Portfolio

Follow Eukles Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.